Tag Archives: Raymond Debbane

A Director at Lexicon Pharmaceuticals (NASDAQ: LXRX) is Buying Shares

Yesterday, a Director at Lexicon Pharmaceuticals (LXRX – Research Report), Raymond Debbane, bought shares of LXRX for $474.7K. This recent transaction increases Raymond Debbane’s holding in the company by 4.77% to a total of $13.63 million. In addition to Raymond